← SynDRA
TARANABANT
SynDRA canonical compound SYN0006423 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | CNR1 |
| Mechanism of action | Cannabinoid receptor inverse agonist |
All known targets
Mechanisms of action (all sources)
- Cannabinoid receptor inverse agonist
- CNR1 INVERSE AGONIST
- Cannabinoid CB1 receptor inverse agonist
- CNR1 ANTAGONIST
- ADRB2 INHIBITOR
- ADRB1 INHIBITOR
Drug classes
- Cannabinoid Receptor Agonists
Cross-references
Synonyms
- L-796568
- Mk-0364
- Mk0364
- MK-0634
- MK0634
- Taranabant [USAN]
- MK-0364
- MK0364
- Taranabant (INN/USAN)
- L]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide
- N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropy
- N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide
- N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide
- N-((1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide
- UNII-P50A5YTO0O
- P50A5YTO0O
- CHEMBL111201
- AC1MI4YO
- L-796568 free base
- SCHEMBL1276546
- BDBM50092645
- N-{4-[2-((R)-2-hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[3-(4-trifluoromethyl-phenyl)-thiazol-2-yl]-benzenesulfonamide
- (R)-N-(4-(2-((2-Hydroxy-2-(pyridin-3-yl)ethyl)amino)ethyl)phenyl)-4-(4-(4-trifluoromethylphenyl)thiazol-2-yl)benzenesulfonamide
- (1R)-1-(3-Pyridyl)-2-[4-[[4-[4-[4-(trifluoromethyl)phenyl]-2-thiazolyl]phenyl]sulfonylamino]phenethylamino]ethanol
- MK 0364
- X9U622S114
- taranabantum
- RefChem:891166
- DTXCID60142955
- Taranabant (MK-0364)
- Tranabant (MK-0364)
- C27H25ClF3N3O2
- Taranabant racemate
- MK-0364 racemate
- Taranabant (racemate)
- Taranabant [USAN:INN]
- Taranbant
- UNII-X9U622S114
Look up TARANABANT in the interactive SynDRA portal →